The effect of Vitamin D on fasting plasma glucose and Insulin levels
Phase 3
Recruiting
- Conditions
- Gestational Diabetes.Gestational diabetes mellitusO24.4
- Registration Number
- IRCT20120718010324N59
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 88
Inclusion Criteria
Pregnant women with gestational age of 8 -10 weeks
Vitamin D levels below 30 ng / ml
Exclusion Criteria
Women with diabetes
Vitamin D levels above 30 ng / ml
Women with thyroid and parathyroid disorders according to the self-report
Women with a history of macrosomic neonate
Women with a body mass index above 30 kg / m2 before pregnancy
Women with pre-pregnancy polycystic ovary syndrome, according to the self-report
Women with a history of diabetes or gestational diabetes
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Insulin resistance index. Timepoint: Before the intervention - 26 weeks of pregnancy. Method of measurement: HOMA-IR index.;Fasting plasma glucose levels. Timepoint: Before the intervention - 26 weeks of pregnancy. Method of measurement: FBS.;Fasting plasma insulin levels. Timepoint: Before the intervention - 26 weeks of pregnancy. Method of measurement: FBI.
- Secondary Outcome Measures
Name Time Method Abortion rate. Timepoint: 26 weeks of pregnancy. Method of measurement: Abortion checklist.;Gestational Diabetes. Timepoint: 26 weeks of pregnancy. Method of measurement: OGTT - FBS.;Depression score. Timepoint: 26 weeks of pregnancy. Method of measurement: Edinburgh Depression Questionnaire.;Side effects. Timepoint: 26 weeks of pregnancy. Method of measurement: Side effects checklist.